Home Rheumatology Nonspecific Thoracic Spine Pain

Nonspecific Thoracic Spine Pain

Introduction to Nonspecific Thoracic Spine Pain

Nonspecific thoracic spine pain (NTSP) is defined as pain localised to the thoracic region (T1–T12) not attributable to a specific recognisable pathology such as fracture, malignancy, infection, inflammatory spondyloarthropathy, or referred visceral pain. It accounts for approximately 15–19% of all spinal pain presentations in primary care, though it is far less studied than cervical or lumbar pain. In Australia, thoracic spine pain is a common presentation to general practice, emergency departments, and musculoskeletal physiotherapy clinics.

ℹ️
Classification: Thoracic spine pain may be acute (<6 weeks), subacute (6–12 weeks), or chronic (>12 weeks). The majority of acute NTSP resolves within weeks. Thoracic pain presenting with neurological symptoms, systemic features, or cardiac/visceral symptoms requires urgent evaluation to exclude serious pathology.
Low Risk
Nonspecific (Mechanical)
No red flags, localised or diffuse, reproduced by movement or posture
GP/physiotherapy — reassurance, activity, analgesia
Moderate Risk
Subacute / Persistent
Persistent >6 weeks, psychosocial yellow flags present, functional limitation
Allied health (physio, psychology), structured rehabilitation
High Risk
Red Flags Present
Neurological deficit, systemic features (fever, weight loss), cardiac/visceral referral pattern
Urgent investigation and/or specialist referral

The 2018 Lancet Low Back Pain Series principles broadly apply to all nonspecific spinal pain including thoracic. The key principle is that biopsychosocial factors — not structural imaging findings — determine chronification and disability. Management should be active, exercise-centred, and avoid overmedicalisation.

Pathophysiology

The thoracic spine has unique biomechanical features compared to the cervical and lumbar spine: greater inherent rigidity due to rib articulations, smaller intervertebral foramina, and a longer kyphotic curve. These features make it both more stable and more prone to postural and muscular pain syndromes.

Structural Sources of Thoracic Pain

  • Costovertebral and costotransverse joint dysfunction: The rib–vertebra joints are common pain generators, particularly in acute thoracic pain with sharp, localised onset
  • Thoracic facet (zygapophyseal) joints: Degeneration and synovial irritation of facet joints produce deep, aching midline or paravertebral pain
  • Thoracic intervertebral discs: Less prone to herniation than lumbar discs; disc degeneration contributes to chronic NTSP
  • Thoracic paraspinal musculature: Muscle spasm and myofascial trigger points (trapezius, rhomboids, erector spinae) — particularly common with sustained flexed posture (desk work, device use)
  • Thoracic ligaments and posterior elements: Supraspinous and interspinous ligament strain

Biopsychosocial Contributors

As with all nonspecific spinal pain, the transition from acute to chronic NTSP is driven by psychosocial factors (yellow flags) rather than structural pathology. Key psychosocial drivers include:

  • Fear-avoidance beliefs — catastrophising, kinesiophobia
  • Depression, anxiety, and sleep disturbance
  • Occupational factors: sedentary desk work, prolonged thoracic flexion, low job control
  • Poor self-efficacy and passive coping styles
  • Prior chronic pain history

Postural and Occupational Contributions

NTSP is strongly associated with sustained thoracic kyphosis in sedentary occupations. Prolonged device use (computers, smartphones) produces anterior head carriage and upper thoracic strain. Thoracic hypomobility from sustained kyphosis increases facet joint loading and muscular overuse.

Clinical Presentation

NTSP presents with pain in the thoracic region, typically described as aching, stiffness, or sharp with movement. It is most commonly midline or paravertebral and may radiate around the chest wall (costochondral/costovertebral pattern). Unlike lumbar or cervical pain, NTSP is less frequently associated with nerve root radiation.

Typical Features of Nonspecific Thoracic Spine Pain

  • Localised thoracic or paravertebral aching or stiffness
  • Pain reproduced or worsened by movement, sustained posture, deep inspiration, or coughing
  • Relief with movement, positional change, or heat
  • No neurological symptoms (no radiculopathy, no myelopathy)
  • Absence of systemic features
  • Common onset with specific postural or occupational triggers (desk work, lifting)

Red Flag Symptoms — Require Urgent Evaluation

⚠️
Red Flags in Thoracic Pain: Thoracic pain has a higher pre-test probability of serious pathology than cervical or lumbar pain. Always screen for:
  • Cardiac: Central chest tightness, exertional pain, radiation to jaw/arm — ACS must be excluded
  • Aortic dissection: Sudden severe tearing pain radiating to back — emergency
  • Pulmonary embolism: Pleuritic chest pain + dyspnoea + risk factors
  • Malignancy: Age >50, insidious onset, night pain, weight loss, prior malignancy
  • Infection: Fever, IV drug use, immunosuppression, recent spinal procedure
  • Vertebral fracture: Osteoporosis, corticosteroid use, major trauma
  • Myelopathy: Upper motor neuron signs, gait disturbance, bladder/bowel dysfunction
  • Inflammatory spondyloarthropathy: Age <40, morning stiffness >1 hour, responds to NSAIDs, sacroiliac involvement

Costochondritis and Tietze Syndrome

Costochondritis (costochondral junction tenderness without swelling) and Tietze syndrome (with visible/palpable swelling) are common causes of anterior chest/thoracic pain. Both are benign, self-limiting conditions often mimicking cardiac pain. Point tenderness on palpation of the costochondral junctions is characteristic.

Investigations

Routine imaging is NOT indicated for NTSP in the absence of red flags. As with all nonspecific spinal pain, imaging findings (disc degeneration, osteophytes, mild kyphosis) are common in asymptomatic individuals and correlate poorly with pain severity. Unnecessary imaging reinforces illness behaviour and increases the likelihood of low-value interventional procedures.

  • Inv-Essential
    No Routine Imaging (Red Flag Absent)
    NTSP without red flags does not require imaging. Imaging is indicated only when red flag features are present or when symptoms fail to improve after 6–8 weeks of appropriate management.
  • Inv-Essential
    ECG and Troponin
    Mandatory in all patients presenting with thoracic pain and any cardiac features (central chest discomfort, exertional onset, radiation pattern, diaphoresis, dyspnoea). Exclude ACS before attributing pain to musculoskeletal cause.
  • Inv-Recommended
    Chest X-Ray
    Appropriate first-line imaging when thoracic pain is accompanied by cough, haemoptysis, dyspnoea, fever, or systemic features. Can detect pneumonia, pleural effusion, mediastinal pathology, and aortic widening.
  • Inv-Recommended
    Thoracic Spine X-Ray
    Indicated if vertebral fracture suspected (osteoporosis, major trauma, corticosteroid use, age >70 with acute onset). Limited sensitivity for fracture — MRI preferred if high clinical suspicion.
  • Inv-Referral
    MRI Thoracic Spine
    Indicated for: myelopathy signs, suspected malignancy, infection, inflammatory arthropathy, or fracture not clearly seen on X-ray. MRI is the gold standard for cord compression, disc pathology, and soft tissue lesions. Refer to specialist if indicated.
  • Inv-Referral
    CT Aortogram
    Urgent if aortic dissection suspected (sudden severe tearing pain, haemodynamic instability, pulse differential). Call for emergency assessment — do not delay for outpatient investigation.
  • Inv-Recommended
    Inflammatory Markers (CRP, ESR)
    If inflammatory spondyloarthropathy, malignancy, or infection suspected. HLA-B27 testing may be appropriate if ankylosing spondylitis is under consideration.
  • Inv-Recommended
    DEXA Scan
    If osteoporotic fracture suspected as cause of thoracic pain (postmenopausal women, men >70, prolonged corticosteroid use). Refer to bone health clinic if T-score <-2.5.

Risk Stratification

Risk stratification guides management intensity and referral pathways. The STarT Back Screening Tool (originally validated for low back pain) has been applied to thoracic pain in clinical practice. The Örebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) is validated for all spinal pain and is used in Australian occupational settings.

Risk CategoryFeaturesManagement Pathway
Low RiskShort duration, no/few yellow flags, good self-efficacy, no functional limitationBrief advice, reassurance, self-management education, analgesia PRN, return to activity
Medium RiskSome yellow flags (mild fear-avoidance, some catastrophising), moderate limitationPhysiotherapy (exercise + manual therapy), education, short-course analgesia
High RiskMultiple yellow flags, significant fear-avoidance, depression/anxiety, poor coping, work disabilityPsychologically-informed physiotherapy, psychology referral, multidisciplinary approach, occupational assessment
Red FlagsNeurological deficits, systemic features, cardiac/visceral referral patternUrgent investigation, specialist referral, appropriate emergency response

Yellow Flags in Thoracic Spine Pain

  • Belief that pain means serious harm (catastrophising)
  • Avoidance of activity due to pain fear (kinesiophobia)
  • Expectation that pain will not improve
  • High pain intensity disproportionate to presentation
  • Job dissatisfaction or occupational distress
  • Social withdrawal due to pain
  • High healthcare utilisation / passive treatment-seeking

Pharmacological Management

Pharmacological management of NTSP follows the same principles as nonspecific low back pain: short-term, lowest-effective-dose, with early de-escalation. The primary goals are pain reduction sufficient to enable activity participation — not complete pain elimination.

Acute NTSP (≤6 weeks)

💊
Ibuprofen
Nurofen® | First-line NSAID for acute NTSP
Adult Dose 400 mg
Frequency Three times daily with food
Duration Up to 2 weeks; review regularly
Route Oral
Renal Adj. Avoid if eGFR <30 mL/min
Hepatic Adj. Use with caution in liver disease
PBS Status ✓ PBS General Benefit
Notes Contraindicated in cardiovascular disease, renal impairment, peptic ulcer disease. Add PPI if GI risk factors present.
💊
Naproxen
Naprogesic® | Alternative NSAID
Adult Dose 250–500 mg
Frequency Twice daily with food
Duration Up to 2 weeks
Route Oral
Renal Adj. Avoid if eGFR <30 mL/min
PBS Status ✓ PBS General Benefit
Notes Preferred NSAID in patients with moderate cardiovascular risk. Add omeprazole 20 mg if >65 years or GI risk.
💊
Paracetamol
Panadol® | Adjunct analgesic
Adult Dose 500–1000 mg
Frequency Every 4–6 hours (max 4 g/day)
Duration Short-term
Route Oral
PBS Status ✓ PBS General Benefit
Notes Limited evidence as monotherapy; useful adjunct with NSAIDs or when NSAIDs contraindicated. Reduce dose in liver impairment.
⚠️
Avoid in Acute NTSP:
  • Opioids: Not recommended for acute NTSP — no superior benefit over NSAIDs; significant harm risk (dependence, falls, sedation)
  • Gabapentinoids: No evidence for nonspecific thoracic pain; significant side effects
  • Systemic corticosteroids: No evidence of benefit for nonspecific thoracic pain
  • Benzodiazepines: Short-term muscle relaxants only if severe spasm; ≤3 days; risk of dependence

Chronic NTSP (>12 weeks)

💊
Duloxetine
Cymbalta® | SNRI for chronic musculoskeletal pain
Adult Dose 30 mg for 1 week → 60 mg daily
Frequency Once daily
Duration Trial ≥8 weeks; continue if benefit
Route Oral
PBS Status ⚠ PBS Restricted (depression/anxiety)
Notes TGA-approved for chronic musculoskeletal pain. Particularly useful with comorbid depression or anxiety. Titrate slowly to reduce nausea.
💊
Amitriptyline
Endep® | Low-dose TCA for sleep and pain (off-label)
Adult Dose 10–25 mg nocte
Frequency Once nightly
Duration Trial 6–8 weeks
Route Oral
PBS Status ✓ PBS General Benefit (depression)
Notes May assist with comorbid sleep disturbance. Avoid in elderly due to anticholinergic effects and falls risk.

Management of Chronic Nonspecific Thoracic Spine Pain

Chronic NTSP (>12 weeks) is a biopsychosocial condition requiring a multimodal, active approach. Passive treatments, repeated imaging, and opioids are ineffective and may cause harm. Functional restoration — not pain elimination — is the treatment goal.

Evidence Hierarchy for Chronic NTSP

  • Strong evidence (recommend): Exercise therapy, cognitive behavioural therapy (CBT), multidisciplinary pain rehabilitation programs, duloxetine (SNRI)
  • Moderate evidence (consider): Manual therapy (spinal manipulation/mobilisation), acupuncture (short-term benefit), NSAIDs (short course for flares)
  • Weak/no evidence (avoid): Long-term opioids, gabapentinoids, systemic corticosteroids, passive treatments as sole modality, spinal surgery (without structural indication)

Exercise Therapy for Chronic NTSP

  • Thoracic mobility exercises: Thoracic extension over foam roller, thoracic rotation stretches, cat-cow exercises — directly target thoracic hypomobility
  • Postural retraining: Scapular retraction, thoracic erector spinae strengthening, deep neck flexor strengthening — addresses postural drivers
  • General aerobic exercise: Walking, swimming, cycling — reduces systemic sensitisation and improves mood and sleep
  • Yoga and Pilates: Improve thoracic mobility, posture, and core stability — modest evidence for chronic spinal pain
  • Referral: Medicare EPC plan (5 allied health visits/year) for exercise physiology or physiotherapy

Postural and Ergonomic Interventions

  • Workstation ergonomic assessment: monitor height, chair height, keyboard position to reduce thoracic kyphotic loading
  • Regular movement breaks every 30–45 minutes during sustained sitting
  • Thoracic support cushions or lumbar-thoracic support for prolonged sitting
  • Smartphone and device use: reduce prolonged flexed neck/thoracic posture
  • Consider standing desk if sedentary occupation is a primary driver

Nonpharmacological Management

Nonpharmacological therapies are the cornerstone of NTSP management at all stages. Simple reassurance and activity advice are sufficient for acute NTSP. Structured active programs are indicated for subacute and chronic NTSP.

Acute NTSP — Core Management

1
Reassure and Educate
Explain that NTSP is common, benign, and usually self-limiting. Avoid catastrophising language. Reinforce that activity will not cause harm.
2
Maintain Activity
Advise against bed rest. Encourage continuation of normal daily activities as tolerated. Gentle movement reduces muscle guarding.
3
Analgesia PRN
Short-course NSAIDs or paracetamol for pain relief sufficient to enable activity participation. Not for continuous long-term use.
4
Heat Therapy
Heat pack to thoracic region — modest evidence for acute pain relief, safe, inexpensive, empowers self-management.
5
Review at 4–6 Weeks
Most acute NTSP resolves. If not improving: reassess for red flags, consider physiotherapy referral, psychosocial screening.

Manual Therapy

Spinal manipulation and mobilisation have modest short-term benefits for thoracic pain. They should be used in combination with active therapies (exercise, education) — not as standalone ongoing treatment.

  • Thoracic manipulation: Evidence supports short-term pain reduction for acute and chronic NTSP; may also reduce cervicogenic headache in upper thoracic pain presentations
  • Thoracic mobilisation (Maitland techniques): Particularly effective for costovertebral dysfunction — reduces sharp, localised thoracic pain with rib articulation movement
  • Rib mobilisation: Targeted for costovertebral and costotransverse joint dysfunction
  • Safety: Thoracic manipulation is generally very safe; serious adverse events are extremely rare. Perform neurological screening before manipulation.

Massage Therapy

  • Myofascial release and trigger point therapy for trapezius, rhomboid, and thoracic erector spinae muscles
  • Short-term pain relief; limited long-term benefit without exercise component
  • Appropriate as adjunct to active therapy in subacute NTSP

Monitoring Parameters

Monitoring for NTSP focuses on functional improvement, treatment response, and timely escalation when symptoms are not resolving as expected.

2–4 Weeks (Acute)
Reassess pain (NRS), functional activity, and red flags. Review analgesia — step down if improving. Consider physiotherapy referral if not improving. Screen for yellow flags (STarT Back or OMPSQ).
6 Weeks
Most acute NTSP should be substantially improved. If not: confirm no red flags, imaging if indicated, physiotherapy with manual therapy and exercise if not yet engaged.
3 Months (Subacute→Chronic)
Formal biopsychosocial assessment. Review medications (step down or cease). Multidisciplinary pathway if not improving. Psychological referral if high fear-avoidance or depression.
6 Months (Chronic)
Review pain scores, function, work status, medication (especially opioids). Functional goals — not pain elimination. Pain clinic referral if complex chronic pain.
Ongoing (Chronic)
Annual review of opioids (if prescribed — taper/cease). Exercise adherence. Mental health and sleep. Functional capacity. Consider occupational assessment if work disability persists.

Treatment Response Measures

MeasureTool / TargetFrequency
Pain intensityNRS 0–10; aim for ≥30% reductionEach visit
Functional disabilityRMDQ or Roland Morris; aim for meaningful improvement4–6 weekly
Psychosocial riskSTarT Back or OMPSQ scoreBaseline and 3 months
Medication reviewNSAID dose, opioid use, adjuvant agentsEach visit
Work statusReturn to work / modified duties4–6 weekly in occupational cases
ℹ️
Flags for Reassessment: Reassess diagnosis if: (1) pain not improving after 6–8 weeks of appropriate management; (2) new neurological symptoms develop; (3) new systemic features (fever, weight loss, night sweats); (4) significant change in pain character. Repeat targeted examination and consider imaging as clinically indicated.

Special Populations

🤰 Pregnancy

Thoracic spine pain is common in pregnancy, particularly in the second and third trimesters, due to postural changes associated with increased thoracic kyphosis and breast weight loading.

  • Physiotherapy, thoracic mobility exercises, hydrotherapy, posture education — safe and effective throughout pregnancy
  • Supportive bras reduce breast-weight thoracic loading significantly
  • Paracetamol: first-line analgesia if required; NSAIDs contraindicated after 20 weeks gestation
  • Manual therapy (soft tissue techniques, gentle mobilisation) by physiotherapist trained in obstetric physiotherapy — appropriate in second and third trimesters
  • Reassure that most pregnancy-related NTSP resolves postpartum

👴 Elderly Patients

  • Thoracic pain in the elderly has a higher pre-test probability of vertebral fracture — screen with FRAX score; DXA if fracture risk high
  • Osteoporotic vertebral fracture presents with acute-onset severe mid-thoracic pain, often after minimal trauma — X-ray first; MRI if X-ray negative but high suspicion
  • Exercise therapy (chair-based, hydrotherapy, tai chi) remains the most effective treatment for NTSP in older adults
  • NSAIDs with great caution — renal function, cardiovascular and GI risk; prefer topical diclofenac gel
  • Avoid opioids — falls, cognitive impairment, constipation; not recommended

💼 Occupational / Sedentary Workers

  • NTSP strongly associated with prolonged sedentary occupations (desk work, coding, assembly line) — ergonomic workstation assessment is therapeutic
  • Avoid prolonged work absence — modified duties and gradual return to work are preferred over sick leave
  • Involve occupational physiotherapist and employer in return-to-work planning
  • Standing desks and activity-permissive workstations may reduce thoracic pain recurrence

🛡️ Patients with Osteoporosis

  • Any thoracic pain in an osteoporotic patient should be imaged to exclude fracture
  • Treat underlying osteoporosis — bisphosphonates, denosumab (PBS-listed in Australia for severe osteoporosis)
  • Exercise: weight-bearing and resistance exercise improve bone density; thoracic extension exercises prevent progressive kyphotic deformity
  • Avoid thoracic flexion loading exercises — spinal flexion under load increases fracture risk in osteoporosis

🛡️ Immunocompromised Patients

  • Thoracic pain in immunocompromised patients (HIV, transplant, prolonged corticosteroids, haematological malignancy) has higher probability of infectious aetiology (spinal tuberculosis, bacterial discitis, epidural abscess)
  • Low threshold for MRI thoracic spine, blood cultures, and specialist referral
  • Spinal TB (Pott's disease) remains a consideration in patients from endemic regions — involves anterior vertebral bodies and discs, psoas abscess on imaging

Aboriginal and Torres Strait Islander Health Considerations

Aboriginal and Torres Strait Islander Health

Nonspecific thoracic spine pain in Aboriginal and Torres Strait Islander communities is influenced by high rates of manual labour, physical occupational demands, psychosocial adversity, limited access to physiotherapy and allied health in remote areas, and cultural factors affecting health-seeking behaviour. Serious causes of thoracic pain — particularly tuberculosis (Pott's disease) and osteoporotic fracture — have higher prevalence in ATSI communities and should be actively excluded.

Access to Allied Health
Exercise-based physiotherapy and manual therapy — the most effective nonpharmacological treatments — are largely unavailable in remote communities. Use GP Management Plans (Medicare EPC, 5 allied health visits/year) and telehealth physiotherapy where available. Aboriginal Health Workers can support exercise adherence programs.
Higher TB Prevalence
Spinal tuberculosis (Pott's disease) has higher prevalence in ATSI communities, particularly in remote NT, WA, and QLD. Any thoracic pain with systemic features (fever, weight loss, night sweats) in an ATSI patient requires Mantoux test, CXR, and MRI thoracic spine. Contact NT or QLD TB Control programs if suspected.
Osteoporosis and Fracture Risk
ATSI women have higher rates of osteoporosis and lower rates of bone-protective treatment. Screen for vertebral fracture in any ATSI woman >50 with acute thoracic pain. DXA access may be limited in remote areas — prioritise for high-risk individuals.
Social and Emotional Wellbeing
Chronic pain in ATSI communities is frequently co-morbid with grief, loss, trauma, and social adversity. A trauma-informed, culturally safe approach is essential. Involve Aboriginal Health Practitioners and community-controlled health organisations. Pain is rarely purely physical in this context.
Opioid Prescribing
Opioid prescribing for NTSP should be minimised in remote settings due to risks of diversion and harm. Use state prescription monitoring programs (SafeScript VIC). Non-pharmacological, exercise-based management preferred. Paracetamol and topical NSAIDs preferred for analgesia.

Appropriate Use of Medicine and Stewardship

Stewardship for NTSP focuses on avoiding high-volume, low-value care: unnecessary imaging, opioid prescribing, passive treatments as sole therapy, and spinal procedures without structural indication.

ℹ️
Choosing Wisely Australia — Thoracic Spine Pain:
  • Do not routinely image NTSP in the absence of red flags
  • Do not prescribe opioids as first-line treatment for NTSP
  • Do not recommend bed rest for NTSP
  • Do not refer for spinal procedures without structural indication
  • Do not prescribe gabapentinoids (pregabalin, gabapentin) for nonspecific thoracic pain

Imaging Stewardship

  • Thoracic spine X-ray and MRI findings (disc degeneration, facet arthropathy, mild kyphosis) are present in >50% of asymptomatic adults — avoid reporting these as the 'cause' of pain
  • Nocebo effect: communicating imaging findings (degeneration, 'wear and tear', 'bone spurs') increases pain catastrophising and disability in patients without structural pathology
  • If imaging is indicated, use the minimum appropriate modality and frame findings neutrally

Opioid Stewardship

  • Long-term opioids for chronic NTSP are NOT recommended — no sustained benefit beyond 3 months; significant harms
  • If opioids already prescribed: implement structured tapering plan (reduce by 5–10% every 2–4 weeks)
  • Support tapering with: CBT, exercise therapy, and specialist addiction medicine referral if opioid-dependent

Gabapentinoid Stewardship

  • Pregabalin and gabapentin have NO evidence of benefit for nonspecific spinal pain and cause significant harms
  • Do not initiate for NTSP; if already prescribed for spinal pain, taper and cease with patient education
  • This includes patients labelled with 'disc disease' or 'nerve pain' without objective radiculopathy

Follow-up and Prevention

Structured follow-up prevents chronification and monitors for red flags. Prevention of recurrence through postural habits, exercise, and workstation management is an integral part of long-term care.

TimepointActionOutcome Goal
2–4 weeks (acute)Reassess pain, activity level, red flags. Review analgesia. Consider physiotherapy referral if not improving.Return to activity; STarT Back stratification
6 weeks (acute)Most should be substantially improved. Review diagnosis if not improving. Physiotherapy if not yet engaged.Low-risk: self-manage. Medium/high-risk: allied health engaged
3 months (subacute→chronic)Biopsychosocial assessment. Review medications. Multidisciplinary pathway if not improving.Exercise commenced; opioids avoided; psychology input if high STarT
6 months (chronic)Review pain, function, work status, medications (opioids)Functional goals — not pain elimination. Pain clinic if complex
Annually (chronic)Review opioids (taper if prescribed), exercise adherence, mental health, functional capacityMaintain function. Optimise modifiable factors.

Prevention of Recurrence

  • Exercise: Regular aerobic exercise plus thoracic-specific mobility and postural strengthening exercises — most evidence-based recurrence prevention strategy
  • Ergonomics: Workstation ergonomic assessment; avoid prolonged thoracic kyphosis; movement breaks every 30–45 minutes
  • Posture awareness: Thoracic extension exercises, scapular retraction, limit prolonged device use in flexed posture
  • Healthy weight: Reduces spinal loading and systemic inflammation
  • Smoking cessation: Impairs disc and vertebral end-plate nutrition
  • Psychosocial: Address depression, anxiety, and job satisfaction — major modifiable risk factors for chronification

References

  • 01
    Briggs AM, et al. Prevalence of thoracic spine pain: a systematic review. Occup Med. 2009;59(7):474–478.
  • 02
    Fouquet N, et al. Prevalence of thoracic spine pain in a surveillance system of musculoskeletal disorders in France. Ann Phys Rehabil Med. 2015;58(4):214–221.
  • 03
    Hartvigsen J, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356–2367.
  • 04
    Foster NE, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391(10137):2368–2383.
  • 05
    Australian Commission on Safety and Quality in Health Care (ACSQHC). Evidence-Based Care in Musculoskeletal Conditions. Sydney: ACSQHC; 2021.
  • 06
    Hill JC, et al. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet. 2011;378(9802):1560–1571.
  • 07
    Sizer PS, et al. Thoracic pain: differential diagnosis and treatment. Pain Pract. 2004;4(4):346–358.
  • 08
    Edmondston SJ, Singer KP. Thoracic spine: anatomical and biomechanical considerations for manual therapy. Man Ther. 1997;2(3):132–143.
  • 09
    Royal Australian College of General Practitioners (RACGP). Prescribing drugs of dependence in general practice — Part C2: The role of opioids in pain management. Melbourne: RACGP; 2020.
  • 10
    Waddell G, et al. A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain. 1993;52(2):157–168.
  • 11
    Kamper SJ, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350:h444.
  • 12
    Australian Rheumatology Association. Clinical guidelines for nonspecific musculoskeletal pain management. Sydney: ARA; 2022.
  • 13
    Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747.